Patient groups | # patients | Hazard ratio | # studies | I2, % |
---|---|---|---|---|
Crude cardiovascular mortality using baseline Cox model | Â | Â | Â | Â |
 Alfacalcitol vs no treatment | 432 | 0.37 (0.25–0.55) | 2 | 0 |
 Calcitrol vs no treatment | 1889 | 0.57 (0.46–0.71) | 1 | NA |
 Paricalcitol vs no treatment | 1230 | 0.31 (0.22–0.44) | 1 | NA |
 Overall | 3551 | 0.41 (0.28–0.59) | 4 | 69.9 |
Adjusted cardiovascular mortality using baseline Cox model | Â | Â | Â | Â |
 Any vitamin D vs no treatment | 466 | 0.59 (0.19–1.82) | 2 | 68.6 |
 Alfacalcitol vs no treatment | 665 | 0.45 (0.14–1.47) | 1 | NA |
 Calcitrol vs no treatment | 1889 | 0.63 (0.50–0.79) | 1 | NA |
 Paricalcitol vs no treatment | 1230 | 0.43 (0.29–0.63) | 1 | NA |
 Overall | 4250 | 0.59 (0.41–0.86) | 5 | 83.6 |